• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Clorox (CLX) And The ERP Case For A Modestly Undervalued Stock

    Simply Wall St·09/02/2026 11:23:10
    Listen to the news

    Zacks recently compared Clorox (CLX) with Ahold NV and assigned Clorox a weaker rank and lower value grade. This contrast has renewed attention on whether Clorox stock still appeals to value-focused investors.

    Clorox shares have come under pressure recently, with a 7 day share price return down 9.5% and a 1 day move down 2.8%, even though the 90 day share price return is up 7.3%. Over longer periods, total shareholder returns over 1, 3 and 5 years have been negative. This suggests recent weakness is reinforcing a longer stretch of softer performance as investors reassess both growth potential and risk around the current US$94.97 share price.

    Compare Clorox with other value candidates under pressure and see which stocks still offer potential upside in the 50 high quality undervalued stocks.

    For bulls, Clorox appears to be a solid household brand that is temporarily out of favor. For bears, the long period of weaker returns suggests a potential value trap. Which side does the current valuation actually support?

    Most Popular Narrative: 6.6% Undervalued

    Clorox's most followed narrative places fair value at $101.71, modestly above the last close at $94.97. That gap is small but it is not trivial for value focused investors watching sentiment weaken.

    The full-scale implementation of a modern ERP system is expected to drive long-term operational efficiencies, improving supply chain visibility, speeding innovation cycles, and reducing structural costs, which should support margin expansion and sustained earnings growth once short-term transition noise normalizes.

    Read the complete narrative. Read the complete narrative.

    Want to understand why this fair value sits above the market price? The narrative leans on steadier revenue progress, improving margins, and a lower future earnings multiple. The mix of higher sales, better profitability and a different valuation anchor does the heavy lifting in this model.

    Result: Fair Value of $101.71 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, Clorox still faces sluggish category growth and heavier price competition, which could pressure margins and challenge the 6.6% undervaluation narrative if these conditions persist.

    Find out about the key risks to this Clorox narrative.

    Next Steps

    With sentiment on Clorox clearly split between risk and reward, move quickly to test the numbers yourself and decide where you stand by reviewing the 2 key rewards and 2 important warning signs.

    Looking for more investment ideas beyond Clorox?

    If you only focus on Clorox today, you could miss other stocks that better match your style. Use the Simply Wall Street Screener to quickly spot fresh opportunities that fit your preferences.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.